SCHEMBL4186280

SCHEMBL4186280

O=C(O)CCCC(=O)c1cccc(O)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 1/20 0.59
HDAC4 P56524 1/20 0.59
HDAC1 Q13547 1/20 0.59
HDAC7 Q8WUI4 1/20 0.59
HDAC2 Q92769 1/20 0.59
HDAC10 Q969S8 1/20 0.59
HDAC11 Q96DB2 1/20 0.59
HDAC8 Q9BY41 1/20 0.59
HDAC6 Q9UBN7 1/20 0.59
HDAC9 Q9UKV0 1/20 0.59
HDAC5 Q9UQL6 1/20 0.59
CA12 O43570 1/20 0.55
CA1 P00915 1/20 0.55
CA2 P00918 1/20 0.55
CA6 P23280 1/20 0.55
CA9 Q16790 1/20 0.55
CTNNB1 P35222 1/20 0.51
L3MBTL1 Q9Y468 2/20 0.50
TDP1 Q9NUW8 2/20 0.50
NPC1 O15118 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3943135 0.96 HDAC1 (0.65) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL4190959 0.89 NR4A2 (0.64) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL30666338 0.89 NR4A2 (0.64) HDAC3HDAC4HDAC1HDAC7HDAC2
Glutarate SCHEMBL2845777 0.85 ALDH1A1 (0.55) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL28310663 0.84 CTNNB1 (0.53) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL4637871 0.82 HSD17B3 (0.62) CA12CA1CA2CA6CA9
SCHEMBL6259203 0.82 CTNNB1 (0.55) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL10632540 0.81 HSD17B3 (0.64) CTNNB1MAPTALDH1A1ESR1
SCHEMBL2743419 0.81 HDAC3 (0.58) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL7826009 0.81 LMNA (0.60) HDAC3HDAC4HDAC1HDAC7HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2023930-A1 IONIZABLE INHIBITORS OF FATTY ACID AMIDE HYDROLASE N.V. Organon (NL) 2009-02-18 EP disclosed
WO-2008020866-A1 IONIZABLE INHIBITORS OF FATTY ACID AMIDE HYDROLASE N.V. ORGANON 2008-02-21 WO disclosed
US-20070155707-A1 IONIZABLE INHIBITORS OF FATTY ACID AMIDE HYDROLASE KADMUS PHARMACEUTICALS, INC. (US) 2007-07-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070155707-A1 IONIZABLE INHIBITORS OF FATTY ACID AMIDE HYDROLASE FAAH, FAAH2, NAAA HDAC3 252/4885HDAC4 313/4885HDAC1 259/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.